AI In Bioinformatics Market Report 2026

AI In Bioinformatics Market Overview

• AI In Bioinformatics market size has reached to $6.14 billion in 2025 • Expected to grow to $37.63 billion in 2030 at a compound annual growth rate (CAGR) of 43.7% • Growth Driver: Rising Clinical Trial Numbers Fueling Growth of AI in Bioinformatics Market • Market Trend: Bionl.AI Platform Revolutionizes Biomedical Research • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under AI In Bioinformatics Market?

AI in Bioinformatics refers to the application of artificial intelligence (AI) techniques and algorithms to analyze and interpret biological data. Bioinformatics involves the management and analysis of large and complex biological datasets, such as genomic sequences, protein structures, and other biological information. The main types of AI in bioinformatics are machine learning, deep learning, and others. Machine Learning (ML) is a subfield of artificial intelligence (AI) that focuses on the development of algorithms and statistical models that enable computer systems to perform tasks without explicit programming. It offers services and software, and it is used for genomics, chemoinformatics and drug design, proteomics, DNA sequencing, system biology, transcriptomics, text mining, microarrays, metabolomics, and other applications.

What Is The AI In Bioinformatics Market Growth Forecast?

The ai in bioinformatics market size is expected to see exponential growth in the next few years. It will grow to $37.63 billion in 2030 at a compound annual growth rate (CAGR) of 43.7%. The growth in the forecast period can be attributed to increasing demand for precision medicine, rising use of AI in clinical decision support, growing pharmaceutical R&D investments, advancements in deep learning architectures, increasing need for faster drug development cycles. Major trends in the forecast period include ai-driven genomic data interpretation, automated drug discovery and target identification, integration of multi-omics data platforms, cloud-based bioinformatics workflows, advanced predictive modeling for protein structures.

What Is The Driver Of The AI In Bioinformatics Market?

The increasing number of clinical trials is expected to propel the growth of AI in the bioinformatics market going forward. Clinical trials refer to a systematic and carefully designed process of conducting medical research involving human participants to evaluate the safety, efficacy, and effectiveness of new medical interventions, treatments, drugs, devices, or therapeutic strategies. AI in bioinformatics is used in clinical trials to analyze patient data from electronic health records and other sources to identify potential candidates for clinical trials who meet specific criteria, improving recruitment efficiency and targeting. For instance, in May 2023, according to Xtalks, a Canada-based life science and medical device platform, on ClinicalTrials.gov, there were 452,604 clinical trials registered worldwide as of May 2023, and 64,838 of the total number of registered studies are actively seeking participants. Further, the number of registered trials has significantly increased from the over 365,000 that were reported at the beginning of 2021. Therefore, the increasing number of clinical trials is driving the growth of AI in the bioinformatics market.

Key Players In The Global AI In Bioinformatics Market

Major companies operating in the ai in bioinformatics market are Dassault Systèmes SE, QIAGEN N.V., SomaLogic Operating Co. Inc., Seven Bridges Genomics Inc., Genialis Inc., SOPHiA GENETICS SA, DNAnexus Inc., Insilico Medicine Inc., Deep Genomics Inc., Biomax Informatics Inc., Ardigen SA, Strand Life Sciences Pvt. Ltd., Genomenon Inc., Fios Genomics Limited, BlueBee Holding BV, JADBio, Elucidata Corporation, Gnosis DA, DNASTAR Inc., iNDX.Ai, Paige AI Inc.

Global AI In Bioinformatics Market Trends and Insights

Major companies operating in the AI in bioinformatics market are innovating technological advancements on the Bionl.AI platform to increase their profitability in the market. Bionl.AI offers an all-in-one workspace for exploration, analysis, and visualization, cutting down the time required to complete complicated tasks from days to minutes. For instance, in October 2023, Bionl Inc., a US-based biomedical and bioinformatics research platform company, launched Bionl.AI, a pioneering platform that aims to revolutionize biomedical and bioinformatics research by providing a no-code solution for researchers, students, and professionals to investigate biomedicine using natural language queries. The platform leverages state-of-the-art GenAI models to enable instant insights and make complex analysis accessible and engaging.

What Are Latest Mergers And Acquisitions In The AI In Bioinformatics Market?

In August 2024, Seqera, a Spain-based provider of scientific data analysis for life sciences and creator of Nextflow, acquired Tinybio for an undisclosed amount. The acquisition aligns with Seqera’s strategy to enhance its capabilities in AI-powered bioinformatics tools and strengthen its online platform for empowering scientists. Tinybio, is a US-based, tech-bio startup specializing in bioinformatics solutions.

What Defines the AI In Bioinformatics Market?

The AI in the bioinformatics market includes revenues earned by entities by providing services such as data analysis and interpretation, biomarker discovery services, clinical decision support, diagnostic imaging software, and biomarker discovery tools. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in the bioinformatics market also includes sales of high-performance computing (HPC) clusters, graphics processing units (GPUs), and field-programmable gate arrays (FPGAs). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the AI In Bioinformatics Market Report 2026?

The ai in bioinformatics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ai in bioinformatics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.